TNF Pharmaceuticals (TNFA) Competitors $4.47 -0.43 (-8.78%) As of 10/7/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock TNFA vs. ALVR, DARE, CVKD, KZR, RNTX, PASG, PYRGF, XCUR, MIRA, and ENLVShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include AlloVir (ALVR), Dare Bioscience (DARE), Cadrenal Therapeutics (CVKD), Kezar Life Sciences (KZR), Rein Therapeutics (RNTX), Passage Bio (PASG), PyroGenesis Canada (PYRGF), Exicure (XCUR), MIRA Pharmaceuticals (MIRA), and Enlivex Therapeutics (ENLV). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors AlloVir Dare Bioscience Cadrenal Therapeutics Kezar Life Sciences Rein Therapeutics Passage Bio PyroGenesis Canada Exicure MIRA Pharmaceuticals Enlivex Therapeutics TNF Pharmaceuticals (NASDAQ:TNFA) and AlloVir (NASDAQ:ALVR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Do institutionals & insiders hold more shares of TNFA or ALVR? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 66.1% of AlloVir shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 32.1% of AlloVir shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher earnings & valuation, TNFA or ALVR? AlloVir is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$23.36M-$231.00-0.02AlloVirN/AN/A-$190.42M-$20.23-0.38 Is TNFA or ALVR more profitable? TNF Pharmaceuticals' return on equity of -69.21% beat AlloVir's return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -69.21% -33.98% AlloVir N/A -71.03%-61.27% Does the media prefer TNFA or ALVR? In the previous week, AlloVir had 1 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 1 mentions for AlloVir and 0 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.00 equaled AlloVir'saverage media sentiment score. Company Overall Sentiment TNF Pharmaceuticals Neutral AlloVir Neutral Do analysts rate TNFA or ALVR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00AlloVir 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, TNFA or ALVR? TNF Pharmaceuticals has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Comparatively, AlloVir has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. SummaryTNF Pharmaceuticals beats AlloVir on 6 of the 10 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.26M$2.64B$6.10B$10.55BDividend YieldN/A56.71%5.69%4.75%P/E Ratio-0.0223.6985.4727.60Price / SalesN/A556.27582.22224.03Price / CashN/A173.2337.9261.55Price / Book0.025.5313.136.76Net Income-$23.36M$32.78M$3.30B$275.88M7 Day Performance6.43%5.82%4.29%2.81%1 Month Performance24.51%13.16%9.45%9.24%1 Year Performance-97.05%1.69%86.64%35.42% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF Pharmaceuticals0.0887 of 5 stars$4.47-8.8%N/A-97.0%$8.26MN/A-0.026Gap DownALVRAlloVirN/A$5.61+17.6%N/A-57.7%$28.29MN/A-0.28110High Trading VolumeDAREDare Bioscience1.8989 of 5 stars$2.13+1.7%$10.00+370.6%-29.8%$28.24M$10K-0.9830Analyst ForecastCVKDCadrenal Therapeutics2.3856 of 5 stars$13.67+1.9%$32.00+134.1%+12.8%$27.98MN/A-1.544Analyst ForecastKZRKezar Life Sciences3.5408 of 5 stars$3.69+2.6%$9.00+144.2%-44.2%$26.97M$7M-0.3860Positive NewsAnalyst ForecastRNTXRein Therapeutics3.0641 of 5 stars$1.150.0%$10.00+769.9%N/A$26.80MN/A-0.439Analyst ForecastPASGPassage Bio3.2981 of 5 stars$8.20+0.7%$75.67+822.8%-32.4%$26.31MN/A-0.46130Positive NewsAnalyst ForecastPYRGFPyroGenesis CanadaN/A$0.14-16.7%N/A-69.1%$26.22M$9.14M-2.3390XCURExicure1.6831 of 5 stars$4.15+6.5%N/A+104.6%$25.82M$500K-1.0550Analyst ForecastGap UpMIRAMIRA Pharmaceuticals0.5453 of 5 stars$1.33-0.4%N/A+20.0%$25.27MN/A-2.702Analyst ForecastENLVEnlivex Therapeutics2.1604 of 5 stars$1.03+2.0%$10.00+870.9%-22.0%$25.16MN/A-1.7970Analyst Forecast Related Companies and Tools Related Companies AlloVir Alternatives Dare Bioscience Alternatives Cadrenal Therapeutics Alternatives Kezar Life Sciences Alternatives Rein Therapeutics Alternatives Passage Bio Alternatives PyroGenesis Canada Alternatives Exicure Alternatives MIRA Pharmaceuticals Alternatives Enlivex Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
